CME/CE
33-48 of 121
Javed Butler, MD
- CME/CE
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
Kevin Alexander, MD
Rajiv Agarwal, MBBS, MD, FASN, BRCU
Amy Mottl, MD, MPH
Muthiah Vaduganathan, MD, MPH
Ahmad Masri, MD, MS
Amy Mottl, MD, MPH
Prof. Christoph Wanner
Muthiah Vaduganathan, MD, MPH
Anu Lala, MD
Brendon Neuen, MBBS, PhD
Riccardo Maria Inciardi, MD, PhD
- DataPulse: Key Clinical Trial Insights on Nonsteroidal MRAs in CKM Syndrome Management
Albuminuria Change and Finerenone's Effect on CV Outcomes
Finnian R. McCausland, MD
prof. Hiddo Heerspink
Jennifer B. Green, MD
Robert J. Mentz, MD, FHFSA, FACC
Piotr Ponikowski, MD, PhD, FESC, FHFA
Daniel Gaudet, MD, PhD
Børge G. Nordestgaard, MD, DMSc
Pam R. Taub, MD, FACC, FASPC
Kausik Ray, MBChB, MD, MPhil
Faiez Zannad, MD, PhD
John McMurray, MD
Daniel Gaudet, MD, PhD
- MinuteCE®
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
1.00 program creditBørge G. Nordestgaard, MD, DMSc
Kausik Ray, MBChB, MD, MPhil
Børge G. Nordestgaard, MD, DMSc
Kausik Ray, MBChB, MD, MPhil
Daniel Gaudet, MD, PhD
Pam R. Taub, MD, FACC, FASPC
